ForeseeHome
Tel Aviv
About ForeseeHome
Notal Vision is developing the first comprehensive diagnostic solution for the early detection and frequent monitoring of Age-Related Macular Degeneration (AMD), the leading cause of blindness in the western world today. Early detection of ARM can allow doctors to treat patients at an earlier stage and possibly prevent any loss of sight. A true pioneer in the eye care industry, Notal Vision has developed and introduced the first home-based monitoring system for AMD patients, the ForeseeHome™ AMD Monitoring Program.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Oct 2016)
- Website: foreseehome.com
- Phone: 7039533339
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/foreseehome-93128 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.